Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management
of early-stage HCC is often successful with highly efficacious treatment modalities such as …

Background There are many potential treatment options for patients with early stage
hepatocellular carcinoma (HCC) and practice patterns vary widely. This project aimed to use …

Hepatocellular carcinoma (HCC) causes a significant health burden globally and its impact
is expected to increase in the coming years. Intermediate stage HCC, as defined by the …

Early and very early stage hepatocellular cancers (HCC) when staged clinically, if they are
coincident with histological early HCC, have the best outcome in terms of recurrence rates …

For patients with early-stage hepatocellular carcinoma (HCC), potentially curative treatment
options exist, including liver transplantation, surgical resection, and ablation therapy. These …

Hepatocellular carcinoma (HCC), in its very early stage, is heterogeneous both in terms of
liver function (ie, presence or absence of portal hypertension, model for end-stage liver …

Background Several treatments are available for treatment of early and very early-stage
Hepatocellular Carcinoma, also known as small Hepatocellular Carcinoma (SHCC) …

Hepatocellular carcinoma (HCC) has constituted a significant health burden worldwide, and
patients with advanced HCC, which is stage C as defined by the Barcelona Clinic Liver …

There are several interventional therapies that improve the prognosis and increase the
survival rate of early-stage hepatocellular carcinoma (early-stage HCC), but it is uncertain …

Background A consensus on the most reliable staging system for hepatocellular carcinoma
(HCC) is still lacking but the most used is a revised Barcelona Clinic Liver Cancer (BCLC) …